Alumis ALMS
NASDAQ ALMS
$6.81 +0.11 (+1.64%)
As of: Oct 21, 2026 · 2:16 PM EDT

Alumis (ALMS) EBIT Margin (2025 - 2026)

Updated

Alumis' EBIT Margin came in at -8956.38% for Q2 2026, down 3684.85 percentage points from -5271.53% a year earlier.

Analysis

Alumis (ALMS) EBIT Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alumis reported EBIT Margin of -6021.04%; for FY2025, it came in at -1886.92%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,134.06 Bn 1,102.65 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 616.49 Bn 535.01 Bn 17.26 Bn 28.21%
3 AbbVie 501.55 Bn 474.66 Bn 12.70 Bn 37.86%
4 Merck 367.24 Bn 321.62 Bn 12.21 Bn -3.52%
5 Novartis Ag 297.99 Bn 261.98 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.48 Bn 235.17 Bn 12.86 Bn 20.57%
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn -133.21%
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn 28.37%
10 Alumis 869.63 Mn -805.21 Mn - -8,956.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,956.38%
Dec 31, 2025 -4,999.74%
Sep 30, 2025 -5,580.45%
Jun 30, 2025 -5,271.53%
Mar 31, 2025 -583.49%
API Access

Alumis EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY